Terms: = Uterine cancer AND PALB2, ENSG00000083093, 79728
18 results:
1. NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024.
Daly MB; Pal T; Maxwell KN; Churpek J; Kohlmann W; AlHilli Z; Arun B; Buys SS; Cheng H; Domchek SM; Friedman S; Giri V; Goggins M; Hagemann A; Hendrix A; Hutton ML; Karlan BY; Kassem N; Khan S; Khoury K; Kurian AW; Laronga C; Mak JS; Mansour J; McDonnell K; Menendez CS; Merajver SD; Norquist BS; Offit K; Rash D; Reiser G; Senter-Jamieson L; Shannon KM; Visvanathan K; Welborn J; Wick MJ; Wood M; Yurgelun MB; Dwyer MA; Darlow SD
J Natl Compr Canc Netw; 2023 Oct; 21(10):1000-1010. PubMed ID: 37856201
[TBL] [Abstract] [Full Text] [Related]
2. Report on the Effect of the Implementation of an Early Detection and Prevention of cancer Program on Families at High Hereditary Risk-Concentrating on Patients Undergoing Genetic Diagnostics and Counseling in Central Poland.
Kałużewski T; Kubiak I; Bednarek M; Sałamunia J; Kucharska D; Kępczyński Ł; Stempień M; Kubicki T; Trzciński R; Gordon-Sönmez Z; Bartosińska-Dyc A; Gach A; Kałużewski B
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685988
[TBL] [Abstract] [Full Text] [Related]
3. Ovarian high-grade serous carcinoma with transitional-like (SET) morphology: a homologous recombination-deficient tumor.
D'Angelo E; Espinosa I; Felicioni L; Buttitta F; Prat J
Hum Pathol; 2023 Nov; 141():15-21. PubMed ID: 37673346
[TBL] [Abstract] [Full Text] [Related]
4. Risk of Syndrome-Associated cancers Among First-Degree Relatives of Patients With Pancreatic Ductal Adenocarcinoma With Pathogenic or Likely Pathogenic Germline Variants.
Chen X; Meyer MA; Kemppainen JL; Horibe M; Chandra S; Majumder S; Petersen GM; Rabe KG
JAMA Oncol; 2023 Jul; 9(7):955-961. PubMed ID: 37200008
[TBL] [Abstract] [Full Text] [Related]
5. Comprehensive analysis of germline drivers in endometrial cancer.
Gordhandas S; Rios-Doria E; Cadoo KA; Catchings A; Maio A; Kemel Y; Sheehan M; Ranganathan M; Green D; Aryamvally A; Arnold AG; Salo-Mullen E; Manning-Geist B; Sia T; Selenica P; Da Cruz Paula A; Vanderbilt C; Misyura M; Leitao MM; Mueller JJ; Makker V; Rubinstein M; Friedman CF; Zhou Q; Iasonos A; Latham A; Carlo MI; Murciano-Goroff YR; Will M; Walsh MF; Issa Bhaloo S; Ellenson LH; Ceyhan-Birsoy O; Berger MF; Robson ME; Abu-Rustum N; Aghajanian C; Offit K; Stadler Z; Weigelt B; Mandelker DL; Liu YL
J Natl Cancer Inst; 2023 May; 115(5):560-569. PubMed ID: 36744932
[TBL] [Abstract] [Full Text] [Related]
6. Genomic Correlates of Unfavorable Outcome in Locally Advanced Cervical cancer Treated with Neoadjuvant Chemoradiation.
Wei Y; Wei C; Chen L; Liu N; Ou Q; Yin JC; Pang J; Fang Z; Wu X; Wang X; Mu D; Shao Y; Yu J; Yuan S
Cancer Res Treat; 2022 Oct; 54(4):1209-1218. PubMed ID: 35038823
[TBL] [Abstract] [Full Text] [Related]
7. Germline palb2 Variants and PARP Inhibitors in Endometrial cancer.
Cilento MA; Poplawski NK; Paramasivam S; Thomas DM; Kichenadasse G
J Natl Compr Canc Netw; 2021 Nov; 19(11):1212-1217. PubMed ID: 34781271
[TBL] [Abstract] [Full Text] [Related]
8. Case-case analysis addressing ascertainment bias for multigene panel testing implicates BRCA1 and palb2 in endometrial cancer.
Johnatty SE; Pesaran T; Dolinsky J; Yussuf A; LaDuca H; James PA; O'Mara TA; Spurdle AB
Hum Mutat; 2021 Oct; 42(10):1265-1278. PubMed ID: 34245638
[TBL] [Abstract] [Full Text] [Related]
9. Screening of cervical cancer-related hub genes based on comprehensive bioinformatics analysis.
Tu S; Zhang H; Yang X; Wen W; Song K; Yu X; Qu X
Cancer Biomark; 2021; 32(3):303-315. PubMed ID: 34151839
[TBL] [Abstract] [Full Text] [Related]
10. Immunohistochemical and genetic characteristics of HPV-associated endocervical carcinoma with an invasive stratified mucin-producing carcinoma (ISMC) component.
Park E; Kim YT; Kim S; Nam EJ; Cho NH
Mod Pathol; 2021 Sep; 34(9):1738-1749. PubMed ID: 34103667
[TBL] [Abstract] [Full Text] [Related]
11. Basaloid Squamous Cell Carcinoma of the uterine Cervix: Report of a Case With Molecular Analysis.
Munkhdelger J; Shimooka T; Koyama Y; Ikeda S; Mikami Y; Fukuoka J; Hori T; Bychkov A
Int J Surg Pathol; 2021 Oct; 29(7):770-774. PubMed ID: 33792431
[TBL] [Abstract] [Full Text] [Related]
12. Report of a germline double heterozygote in MSH2 and palb2.
Agiannitopoulos K; Papadopoulou E; Tsaousis GN; Pepe G; Kampouri S; Patsea E; Lypas G; Nasioulas G
Mol Genet Genomic Med; 2020 Oct; 8(10):e1242. PubMed ID: 32853479
[TBL] [Abstract] [Full Text] [Related]
13. Rare Hereditary Burden associated with a Hypercalcemic Small-Cell Carcinoma of Cervix in a Young Female Patient.
Hruška L; Sirák I; Laco J; Fridrichová P; Nosková H; Slabý O; Pál K; Bočkayová V; Hodek M; Petera J
Klin Onkol; 2019; 32(6):456-462. PubMed ID: 31842565
[TBL] [Abstract] [Full Text] [Related]
14. Screening for hereditary cancers in patients with endometrial cancer reveals a high frequency of germline mutations in cancer predisposition genes.
Tian W; Bi R; Ren Y; He H; Shi S; Shan B; Yang W; Wang Q; Wang H
Int J Cancer; 2019 Sep; 145(5):1290-1298. PubMed ID: 31054147
[TBL] [Abstract] [Full Text] [Related]
15. The clinical importance of BRCAness in a population-based cohort of Danish epithelial ovarian cancer.
Hjortkjær M; Malik Aagaard Jørgensen M; Waldstrøm M; Ørnskov D; Søgaard-Andersen E; Jakobsen A; Dahl-Steffensen K
Int J Gynecol Cancer; 2019 Jan; 29(1):166-173. PubMed ID: 30640700
[TBL] [Abstract] [Full Text] [Related]
16. Women with breast and uterine cancer are more likely to harbor germline mutations than women with breast or uterine cancer alone: A case for expanded gene testing.
Fulk K; Milam MR; Li S; Yussuf A; Black MH; Chao EC; LaDuca H; Stany MP
Gynecol Oncol; 2019 Mar; 152(3):612-617. PubMed ID: 30612783
[TBL] [Abstract] [Full Text] [Related]
17. [Current clinical issues and recent trends in hereditary breast and ovarian cancer in Japan-genetic testing for HBOC and risk-reducing surgery].
Arai M; Iwase T; Takazawa Y; Takeshima N
Gan To Kagaku Ryoho; 2014 Nov; 41(11):1333-9. PubMed ID: 25434434
[TBL] [Abstract] [Full Text] [Related]
18. A novel germline palb2 deletion in Polish breast and ovarian cancer patients.
Dansonka-Mieszkowska A; Kluska A; Moes J; Dabrowska M; Nowakowska D; Niwinska A; Derlatka P; Cendrowski K; Kupryjanczyk J
BMC Med Genet; 2010 Feb; 11():20. PubMed ID: 20122277
[TBL] [Abstract] [Full Text] [Related]
